User profiles for Dominique P.V. de Kleijn

Dominique PV de Kleijn

Experimental Vascular Surgery
Verified email at umcutrecht.nl
Cited by 30208

Frameshift mutants of β amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients

FW Van Leeuwen, DPV de Kleijn, HH van den Hurk… - Science, 1998 - science.org
The cerebral cortex of Alzheimer's and Down syndrome patients is characterized by the
presence of protein deposits in neurofibrillary tangles, neuritic plaques, and neuropil threads. …

The innate immune response in reperfused myocardium

…, F Arslan, Y Appelman, DPV de Kleijn - Cardiovascular …, 2012 - academic.oup.com
One of the major therapeutic challenges in the arena of interventional cardiology is to
design strategies aimed at reducing myocardial tissue damage after myocardial infarction. In …

Arterial remodeling in atherosclerosis, restenosis and after alteration of blood flow: potential mechanisms and clinical implications

G Pasterkamp, DPV de Kleijn… - Cardiovascular research, 2000 - academic.oup.com
Arterial remodeling is currently being recognized as an important determinant in vascular
pathology in which narrowing of the lumen is the predominant feature. Not only expansive …

[HTML][HTML] Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury

…, CN Lee, RM El Oakley, G Pasterkamp, DPV de Kleijn… - Stem cell …, 2010 - Elsevier
Human ESC-derived mesenchymal stem cell (MSC)-conditioned medium (CM) was previously
shown to mediate cardioprotection during myocardial ischemia/reperfusion injury through …

[HTML][HTML] Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium

…, A Choo, CN Lee, G Pasterkamp, DPV de Kleijn - Stem cell …, 2008 - Elsevier
Although paracrine effects of mesenchymal stem cells (MSCs) have been suggested previously,
cardioprotection by human MSC secretions has never been demonstrated. Human MSC…

Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: a prognostic study

…, PC De Bruin, A Vink, E Velema, DPV de Kleijn… - Circulation, 2010 - Am Heart Assoc
Background— Identification of patients at risk for primary and secondary manifestations of
atherosclerotic disease progression is based mainly on established risk factors. The …

Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury

L Timmers, JPS Henriques, DPV de Kleijn… - Journal of the American …, 2009 - jacc.org
Objectives : This study sought to examine whether exenatide is capable of reducing myocardial
infarct size. Background : Exenatide is a glucagon-like peptide (GLP)-1 analogue with …

[HTML][HTML] Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction

…, PA Doevendans, G Pasterkamp, DPV de Kleijn - Stem cell …, 2011 - Elsevier
Recent studies suggest that the therapeutic effects of stem cell transplantation following
myocardial infarction (MI) are mediated by paracrine factors. One of the main goals in the …

Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti–toll-like receptor-2 …

…, PA Doevendans, G Pasterkamp, DPV De Kleijn - Circulation, 2010 - Am Heart Assoc
Background— Reperfusion therapy for myocardial infarction is hampered by detrimental
inflammatory responses partly via Toll-like receptor (TLR) activation. Targeting TLR signaling …

Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery

…, AH Schoneveld, DJ Hijnen, DPV de Kleijn… - Atherosclerosis, 2000 - Elsevier
Atherosclerotic luminal narrowing is determined by plaque mass and the mode of
geometrical remodeling. Recently, we reported that the type of atherosclerotic remodeling is …